Glenmark launches Covid-19 drug at Rs 103 per tablet

Drug firm Glenmark Pharmaceuticals launched antiviral drug Favipiravir, under the brand name FabiFlu, for treatment of patients with mild to moderate Covid-19 at a price of about Rs 103/tablet.
It is the first oral favipiravir-approved medication in India.
It has shown improvement of up to 88% in mild to moderate cases.